Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 7/20 | 0.67 |
| ▸ | SERPINC1 | P01008 | 4/20 | 0.46 |
| ▸ | F2 | P00734 | 2/20 | 0.41 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.40 |
| ▸ | FGF1 | P05230 | 4/20 | 0.39 |
| ▸ | FGF2 | P09038 | 1/20 | 0.38 |
| ▸ | BMP2 | P12643 | 2/20 | 0.37 |
| ▸ | VEGFA | P15692 | 2/20 | 0.37 |
| ▸ | CXCL12 | P48061 | 2/20 | 0.37 |
| ▸ | SHH | Q15465 | 2/20 | 0.37 |
| ▸ | IFNG | P01579 | 1/20 | 0.37 |
| ▸ | PF4 | P02776 | 1/20 | 0.37 |
| ▸ | CCL2 | P13500 | 1/20 | 0.37 |
| ▸ | SELP | P16109 | 1/20 | 0.37 |
| ▸ | BMP6 | P22004 | 1/20 | 0.37 |
| ▸ | CCL11 | P51671 | 1/20 | 0.37 |
| ▸ | WNT3A | P56704 | 1/20 | 0.37 |
| ▸ | SELPLG | Q14242 | 1/20 | 0.37 |
| ▸ | BDNF | P23560 | 2/20 | 0.36 |
| ▸ | PTN | P21246 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14960713 | 0.89 | F10 (0.81) | F10SERPINC1F2HPSEFGF1 | |
| SCHEMBL15199336 | 0.89 | F10 (0.81) | F10SERPINC1F2HPSEFGF1 | |
| SCHEMBL18883211 | 0.89 | F10 (0.81) | F10SERPINC1F2HPSEFGF1 | |
| SCHEMBL14665995 | 0.89 | F10 (0.81) | F10SERPINC1F2HPSEFGF1 | |
| SCHEMBL10157440 | 0.89 | F10 (0.81) | F10SERPINC1F2HPSEFGF1 | |
| SCHEMBL13130300 | 0.88 | F10 (0.84) | F10SERPINC1F2HPSEFGF1 | |
| SCHEMBL29308178 | 0.85 | F10 (0.79) | F10SERPINC1F2HPSEFGF1 | |
| SCHEMBL15984561 | 0.85 | F10 (0.66) | F10SERPINC1F2HPSEFGF1 | |
| SCHEMBL14960707 | 0.84 | F10 (0.61) | F10SERPINC1F2HPSEFGF1 | |
| SCHEMBL24064572 | 0.83 | F10 (0.74) | F10SERPINC1F2HPSEFGF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130129632-A1 | Quantum dot materials, methods for making them, and uses thereof | DUKE UNIVERSITY | 2013-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130129632-A1 | Quantum dot materials, methods for making them, and uses thereof | CLN6, SOD3, SOD1 | F10 4821/4885SERPINC1 4191/4885F2 4806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.